John Mendlein
Founder at FATE THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
John D.
Mendlein is the founder of Fate Therapeutics, Inc. (founded in 2007) and holds the title of Vice Chairman.
He is also the founder of Homes for Sudan.
Dr. Mendlein's current jobs include Chairman at Chimeros Therapeutics, Director at Ohana Biosciences, Inc., Independent Director at Omega Therapeutics, Inc., Director at Tessera Therapeutics, Inc., Director at Empress Therapeutics, Inc., and Executive Partner at Flagship Pioneering.
Dr. Mendlein's former jobs include Chairman & Chief Executive Officer at Adnexus (2005-2008), Chairman & Chief Executive Officer at Affinium Pharmaceuticals Ltd.
(2000-2005), Chairman & Chief Executive Officer at Laronde, Inc. (2022), Director & Chief Knowledge Officer at Aurora Biosciences Corp.
(1996-2001), Director at ACLARA Biosciences, Inc. (2003-2004), Director at Monogram Biosciences, Inc. (2004-2009), Independent Director at aTyr Pharma, Inc. (2010-2019), Director at Chimeros, Inc., Director at Biotechnology Innovation Organization, Director at Axcella Health, Inc., Independent Director at Editas Medicine, Inc., Director at Repertoire Immune Medicines, Inc., Director at Senda Biosciences, Inc., Attorney at Cooley LLP, Scientist at GlaxoSmithKline Pharmaceuticals SA (Belgium), and President-Corporate & Product Strategy at Moderna, Inc. (2018-2019).
Dr. Mendlein's education includes a doctorate from the University of California, Los Angeles, an undergraduate degree from the University of Miami, and a graduate degree from the University of California, Hastings.
Dr. Mendlein is also the founder of Homes for Sudan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FATE THERAPEUTICS, INC.
0.31% | 2023-06-05 | 311,231 ( 0.31% ) | 2 M $ | 2024-03-30 |
OMEGA THERAPEUTICS, INC.
-.--% | 2023-06-06 | 0 ( -.--% ) | - $ | 2024-03-30 |
John Mendlein active positions
| Companies | Position | Start |
|---|---|---|
| FATE THERAPEUTICS, INC. | Founder | 2007-04-26 |
| OMEGA THERAPEUTICS, INC. | Director/Board Member | 2019-12-31 |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Analyst | 2019-01-31 |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
| Homes for Sudan | Founder | - |
Chimeros Therapeutics
 Chimeros Therapeutics Medical SpecialtiesHealth Technology Chimeros Therapeutics develops cancer therapeutic treatment services. The company is headquartered in San Diego, CA. | Chairman | 2009-09-16 |
Empress Therapeutics, Inc.
 Empress Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Empress Therapeutics, Inc. is a company that was founded by Flagship Pioneering in 2020. The company is based in Cambridge, MA. Empress Therapeutics generates medicines quickly by using the chemistry inside the human body. The company uses the Empress Chemilogics™ platform to create first- or oral medicines for a broad range of diseases quickly, predictably, and cost-effectively. The platform uses novel insights that connect the lines of code in DNA with drug-like chemistry made in the human body. Jason Park is the founder of the company and has been the CEO since incorporation. | Director/Board Member | - |
Former positions of John Mendlein
| Companies | Position | End |
|---|---|---|
| ATYR PHARMA, INC. | Chief Executive Officer | 2017-10-31 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of John Mendlein
| University of California, Los Angeles | Doctorate Degree |
| University of Miami | Undergraduate Degree |
| University of California, Hastings | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| AXCA HEALPAR | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| OMEGA THERAPEUTICS, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Private companies | 18 |
|---|---|
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Health Technology |
ACLARA Biosciences, Inc.
 ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | Health Technology |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Commercial Services |
Chimeros, Inc.
 Chimeros, Inc. Pharmaceuticals: MajorHealth Technology Chimeros, Inc. develops novel therapies for cancer treatment. It focuses on the development of novel targeted treatments while generating immediate revenues from licensing platform rights and development contracts. Chimeros was founded in 2004 and is headquartered in San Diego, CA. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Health Technology |
Affinium Pharmaceuticals Ltd.
 Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Affinium Pharmaceuticals Ltd. is a holding company, which engages in the provision of clinical development of antibacterial. It specializes in hte development of antibiotics that targets the bacterial fatty acid synthesis pathway. It focuses on small molecule antibacterials targeting FabI, an essential enzyme in the bacterial fatty acid cycle. The company was founded in 2000 and is headquartered in Austin, TX. | Health Technology |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Cooley LLP engages in the provision of legal services. It offers strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. Its practices include commercial litigation; patent counseling and prosecution; employment and labor; asset recovery; and estate planning and personal representation. The company was founded in 1920 and is headquartered in New York, NY. | Commercial Services |
Chimeros Therapeutics
Chimeros Therapeutics Medical SpecialtiesHealth Technology Chimeros Therapeutics develops cancer therapeutic treatment services. The company is headquartered in San Diego, CA. | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
| Homes for Sudan | |
Ohana Biosciences, Inc.
Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Commercial Services |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Health Technology |
Empress Therapeutics, Inc.
Empress Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Empress Therapeutics, Inc. is a company that was founded by Flagship Pioneering in 2020. The company is based in Cambridge, MA. Empress Therapeutics generates medicines quickly by using the chemistry inside the human body. The company uses the Empress Chemilogics™ platform to create first- or oral medicines for a broad range of diseases quickly, predictably, and cost-effectively. The platform uses novel insights that connect the lines of code in DNA with drug-like chemistry made in the human body. Jason Park is the founder of the company and has been the CEO since incorporation. | Health Technology |
Laronde Inc.
 Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Laronde Inc. is a company that aims to advance eRNA-based therapeutics through their powerful new platform called endless RNA (eRNA™). The company is based in Cambridge, MA and was founded by Noubar B. Afeyan. This platform can be programmed to make any therapeutic protein inside the body, making it the most versatile RNA platform for life-changing medicines. | Commercial Services |
- Stock Market
- Insiders
- John Mendlein
